Systemic lidocaine and mexiletine for the treatment of a patient with total ulcerative colitis

Posted by Michael Jannicelli | Dec 21, 2024 | Uncategorized | 0 |

LETTER Gut. 2005 Mar;54(3):441. doi: 10.1136/gut.2004.055525

PMCID: PMC1774406 PMID: 15711001

In basic research, neural modulation in ulcerative colitis has been shown.1 In clinical settings, local anaesthetics such as lidocaine and ropivacaine were used, administered per rectum, for the treatment of distal ulcerative colitis with a response…

Michael Jannicelli

Michael Jannicelli - "A PROVEN BUSINESS FIRESTARTER & BRANDING GENIUS" a true natural born Trendsetter. • Created over 100 products under 3 brands, sold in 30+ countries worldwide and influencing youth across the globe. • Featured in Forbes magazine +over 100 print publications, television talk shows, major motion pictures and national radio stations. • Co-founder and VP of Bliss beverage USA and President/co-founder of Socko International - fastest growing privately held beverage company in US (Forbes) with Hogan Energy & Raw Energy WWE. • Co-founder of Throwdown Industries (2003) - leading brand in multibillion dollar Impact/Action Sports Market (products designed for superior MN • Diagnosed with auto-immune diseases aged 13; using his experience to help others and promote a positive message while developing edgy products to benefit people with chronic illness.